The proposed acquisition will be the company’s biggest deal in more than a decade and represents an early move by new CEO Kai ...

German drugmaker Merck KGaA said on Thursday ‌it would buy U.S. firm Bio-Techne for $11.3 billion, its biggest deal in more ...

Merck KGaA, Darmstadt, Germany, Collaborates with Versant Ventures to Launch Saturnus Bio to Advance Treatments for Rare ...

June 25 (Reuters) - Merck KGaA has agreed to acquire biotech firm Bio-Techne Corp for $11.3 billion, the German science and ...

DARMSTADT, Germany--(BUSINESS WIRE)--Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced a strategic collaboration with Jiangsu Hengrui Pharmaceuticals Co. Ltd.

A German company that provides products and services that accelerate drug development and manufacturing is set to acquire the ...

April 24 (Reuters) - Germany's Merck KGaA (MRCG.DE), opens new tab said on Thursday it is in late-stage talks to acquire U.S.-based SpringWorks Therapeutics (SWTX.O), opens new tab for about $3.5 ...

DARMSTADT, Germany--(BUSINESS WIRE)-- Merck KGaA, Darmstadt, Germany (DAX: MRK), a leading science and technology company, and SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a Stamford, ...

LINCOLNSHIRE, Ill. & DARMSTADT, Germany--(BUSINESS WIRE)--Zebra Technologies Corporation (NASDAQ: ZBRA), a global leader in digitising and automating frontline workflows, and Merck KGaA, Darmstadt, ...

Germany's Merck KGaA has announced a major acquisition agreement to buy U.S.-based life sciences company Bio-Techne Corp ...